Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor In the article by Davies and Welch, “Current Thyroid Cancer Trends in the United States,”1 the authors draw some questionable conclusions and make potentially dangerous suggestions.
Davies and Welch1 assert that the rise in thyroid cancer rates can be attributed to a rise in subclinical papillary thyroid cancer (PTC) tumors discovered incidentally, such as in “serendipitous detection.” They base this solely on statistical analyses of Surveillance, Epidemiology, and End Results (SEER) data. However, at least 2 studies2,3 find 12.4% or less of patients have nodules discovered during imaging for a different purpose.
Banach R. Davies and Welch Draw Unfounded Conclusions About Thyroid Cancer From Epidemiological Data. JAMA Otolaryngol Head Neck Surg. 2014;140(7):678–679. doi:10.1001/jamaoto.2014.942
Customize your JAMA Network experience by selecting one or more topics from the list below.